Research ArticleClinical Studies
A Simple Clinical Instrument to Predict the Survival Probability of Breast Cancer Patients Receiving Radiotherapy for Bone Metastases
STEFAN JANSSEN, RAPHA HAUS, STEVEN E. SCHILD and DIRK RADES
Anticancer Research January 2020, 40 (1) 367-371; DOI: https://doi.org/10.21873/anticanres.13961
STEFAN JANSSEN
1Departments of Radiation Oncology, University of Lübeck, Lübeck, Germany
2Medical Practice for Radiotherapy and Radiation Oncology, Hannover, Germany
RAPHA HAUS
1Departments of Radiation Oncology, University of Lübeck, Lübeck, Germany
STEVEN E. SCHILD
3Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U.S.A.
DIRK RADES
1Departments of Radiation Oncology, University of Lübeck, Lübeck, Germany
In this issue
Anticancer Research
Vol. 40, Issue 1
January 2020
A Simple Clinical Instrument to Predict the Survival Probability of Breast Cancer Patients Receiving Radiotherapy for Bone Metastases
STEFAN JANSSEN, RAPHA HAUS, STEVEN E. SCHILD, DIRK RADES
Anticancer Research Jan 2020, 40 (1) 367-371; DOI: 10.21873/anticanres.13961
Jump to section
Related Articles
- No related articles found.
Cited By...
- Independent External Validation of the METSSS Model Predicting Survival After Palliative Radiotherapy
- Sleep Disorders in Patients With Breast Cancer Prior to a Course of Radiotherapy - Prevalence and Risk Factors
- Independent Validation of a Comprehensive Machine Learning Approach Predicting Survival After Radiotherapy for Bone Metastases